The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: A prospective, matched analysis.

BACKGROUND Limited information is available on the financial impact of central venous catheter-associated bloodstream infection (BSI) in Argentina. To calculate the cost of BSIs in the intensive care department (ICU), a 5-year prospective nested case-control study was undertaken at 3 hospitals in Argentina. METHODS We studied 6 adult ICUs from 3 hospitals. In all, 142 patients with BSI and 142 control patients without BSI were matched for hospital, type of ICU, year of admission, length of stay, sex, age, and average severity of illness score. Patients' length of stay in the ICU was obtained prospectively on daily rounds. The hospitals' finance departments provided the cost of each ICU day. The hospitals' pharmacies provided the cost of antibiotics prescribed for BSIs. RESULTS The mean extra length of stay for patients with BSI compared with control patients was 11.9 days, the mean extra antibiotic defined daily dose was 22.6, the mean extra antibiotic cost was $1913, the mean extra cost was $4888.42, and the excess mortality was 24.6%. CONCLUSIONS In this study, patients with central venous catheter-associated BSI experienced significant prolongation of hospitalization, increased use of health care costs, and a higher attributable mortality. These findings support the need to implement preventative interventions for patients hospitalized with central venous catheters in Argentina.

[1]  A. Lenaerts,et al.  Catheter manipulations and the risk of catheter-associated bloodstream infection in neonatal intensive care unit patients. , 2001, The Journal of hospital infection.

[2]  D. Pittet,et al.  Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. , 1994, JAMA.

[3]  D. Heaney,et al.  General practice fundholding: observations on prescribing patterns and costs using the defined daily dose method. , 1993, BMJ.

[4]  B. Farr,et al.  Morbidity and Mortality Associated with Multiple Episodes of Nosocomial Bloodstream Infection: A Cohort Study , 1989, Infection Control & Hospital Epidemiology.

[5]  J. Tokars,et al.  Prospective Evaluation of Risk Factors for Bloodstream Infection in Patients Receiving Home Infusion Therapy , 1999, Annals of Internal Medicine.

[6]  E. Larson,et al.  Draft APIC guideline for handwashing and hand antisepsis in health care settings , 1994 .

[7]  R Consunji,et al.  Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. , 2001, Archives of surgery.

[8]  P. Collignon.  Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. , 1994, The Medical journal of Australia.

[9]  E. Larson,et al.  APIC guideline for handwashing and hand antisepsis in health care settings. , 1995, American journal of infection control.

[10]  CDC definitions for nosocomial infections, 1988. , 1989, The American review of respiratory disease.

[11]  J M Hughes,et al.  CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.

[12]  M. Simberkoff,et al.  Excess mortality in critically ill patients with nosocomial bloodstream infections. , 1991, Chest.

[13]  J. Gowardman,et al.  Central venous catheter-related bloodstream infections: an analysis of incidence and risk factors in a cohort of 400 patients , 1998, Intensive Care Medicine.

[14]  V. Rosenthal,et al.  Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. , 2003, American journal of infection control.

[15]  R. Ellison.  Guidelines for the Prevention of Intravascular Catheter-Related Infections , 2002 .

[16]  A. Karchmer.  Nosocomial bloodstream infections: organisms, risk factors, and implications. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  R. D. McCormick,et al.  Effect of education and performance feedback on handwashing: the benefit of administrative support in Argentinean hospitals. , 2003, American journal of infection control.

[18]  M. Beach,et al.  Consequences of intravascular catheter sepsis , 1994 .

[19]  A. Sitges-Serra.  Strategies for prevention of catheter-related bloodstream infections , 1999, Supportive Care in Cancer.

[20]  R. Gaynes,et al.  The National Nosocomial Infections Surveillance System: plans for the 1990s and beyond. , 1991, The American journal of medicine.

[21]  M. Higgins,et al.  The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. , 1999, American journal of respiratory and critical care medicine.

[22]  P A Gross,et al.  Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Society for Healthcare Epidemiology of America. , 1998, Infection control and hospital epidemiology.

[23]  D. Pittet,et al.  Association of secondary and polymicrobial nosocomial bloodstream infections with higher mortality , 1993, European Journal of Clinical Microbiology and Infectious Diseases.

[24]  G. B. Orsi,et al.  Hospital-Acquired, Laboratory-Confirmed Bloodstream Infection: Increased Hospital Stay and Direct Costs , 2002, Infection Control & Hospital Epidemiology.

[25]  Jeanne E. Zack,et al.  Nosocomial primary bloodstream infections in intensive care unit patients in a nonteaching community medical center: a 21-month prospective study. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  L. Leibovici,et al.  Excess mortality in women with hospital-acquired bloodstream infection. , 2001, The American journal of medicine.

[27]  D. Maki,et al.  The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  D. Maki,et al.  The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  S. Jamulitrat,et al.  Factors affecting mortality outcome and risk of developing nosocomial bloodstream infection. , 1994, Infection control and hospital epidemiology.

[30]  D. Monnet,et al.  Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. , 2000, International journal of antimicrobial agents.

[31]  D. Maki,et al.  A semiquantitative culture method for identifying intravenous-catheter-related infection. , 1977, The New England journal of medicine.

[32]  V. Rosenthal,et al.  Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina. , 2003, American journal of infection control.

[33]  P. Collignon.  Intravascular catheter associated sepsis: a common problem , 1994 .

[34]  D. Pittet,et al.  Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. , 1995, Archives of internal medicine.

[35]  M. Kollef,et al.  Antibiotic use and antibiotic resistance in the intensive care unit: are we curing or creating disease? , 1994, Heart & lung : the journal of critical care.

[36]  L. Mermel,et al.  Prevention of Central Venous Catheter-Related Bloodstream Infection by Use of an Antiseptic-Impregnated Catheter , 1997, Annals of Internal Medicine.

[37]  J. Rello,et al.  Evaluation of outcome of intravenous catheter-related infections in critically ill patients. , 2000, American journal of respiratory and critical care medicine.